25 Results for "

Dapagliflozin

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "Dapagliflozin" in MCE Product Catalog:

72
72 Cited Publications
Cat. No.: HY-10450
CAS No.: 461432-26-8
Purity:  99.97%
Synonyms: BMS-512148
Target:  

SGLT

Research Areas:  

Metabolic Disease Cancer

Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
72
72 Cited Publications
Cat. No.: HY-10450A
CAS No.: 960404-48-2
Purity:  99.97%
Synonyms: BMS-512148 (2S)-1,2-propanediol, hydrate
Target:  

SGLT

Research Areas:  

Metabolic Disease Cancer

Dapagliflozin ((2S)-1,2-propanediol, hydrate) is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin ((2S)-1,2-propanediol, hydrate) induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
Cat. No.: HY-I1120
CAS No.: 864070-37-1
Target:  

SGLT

Research Areas:  

Metabolic Disease

SGLT2-IN-1 (Compound 5) is an inhibitor for sodium-dependent glucose cotransporter (SGLT2), with IC50 of 33 nM in CHO cells transfected with human SGLT2. SGLT2-IN-1 is selective for SGLT2 over SGLT1. SGLT2-IN-1 is an active metabolite of dapagliflozinactive metabolite of dapagliflozin .
loading...
    loading...
Cat. No.: HY-128723
CAS No.: 960404-86-8
Purity:  99.63%
Target:  

SGLT

Research Areas:  

Others

Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor .
loading...
    loading...
Cat. No.: HY-10450S
CAS No.: 1204219-80-6
Purity:  98.01%
Synonyms: BMS-512148-d5
Dapagliflozin-d5 is a deuterium labeled Dapagliflozin (HY-10450). Dapagliflozin is a competitive SGLT2 inhibitor .
loading...
    loading...
Cat. No.: HY-10450R
CAS No.: 461432-26-8
Synonyms: BMS-512148 (Standard)
Research Areas:  

Metabolic Disease Cancer

Dapagliflozin (Standard) is the analytical standard of Dapagliflozin. This product is intended for research and analytical applications. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
Cat. No.: HY-W018697
CAS No.: 42860-10-6
Synonyms: Dapagliflozin Impurity 50
Target:  

Drug Intermediate

Research Areas:  

Others

3-Bromo-4-chlorobenzoic acid (Dapagliflozin Impurity 50) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-400785
CAS No.: 2452300-94-4
Target:  

Drug Derivative

Research Areas:  

Cancer

Dapagliflozin impurity A (Compound A) is a dapagliflozin peroxide, a genotoxic impurity, can cause damage to human genetic material at very low concentrations, leading to genetic mutations and possibly tumorigenesis .
loading...
    loading...
Cat. No.: HY-Z0437
CAS No.: 1632287-34-3
Target:  

SGLT

Research Areas:  

Metabolic Disease

Dapagliflozin methyl acetate is an orally active SGLT2 inhibitor. Dapagliflozin methyl acetate may be used in type 2 diabetes research .
loading...
    loading...
Cat. No.: HY-122473
CAS No.: 1181681-43-5
Target:  

SGLT

Research Areas:  

Metabolic Disease

fluoro-Dapagliflozin, a structural analog of Dapagliflozin, is a selective SGLT2 inhibitor with Ki values of 5.3 nM and 330 nM for SGLT2 and SGLT1, respectively. fluoro-Dapagliflozin blocks glucose transport and glucose-coupled currents .
loading...
    loading...
Cat. No.: HY-10450S5
Dapagliflozin- 13C6-1 is 13C labeled Dapagliflozin. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
Cat. No.: HY-137145
CAS No.: 1408245-02-2
Target:  

SGLT

Research Areas:  

Others

Galacto-dapagliflozin is a selective inhibitor for hSGLT2 with Ki of 25 nM .
loading...
    loading...
Cat. No.: HY-125156
CAS No.: 1351438-75-9
Purity:  ≥99.0%
Synonyms: BMS-801576
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Dapagliflozin-3-O-β-D-glucuronide (BMS-801576) is the metabolite of Dapagliflozin (HY-10450), and is formed in the liver and kidney by uridine diphosphate glucuronosyltransferase-1A9 (UGT1A9). Dapagliflozin is a selective inhibitor for SGLT2, that can be used to improve glycemic control and attenuate type 2 diabetes .
loading...
    loading...
Cat. No.: HY-10450S2
CAS No.: 1224234-25-6
Synonyms: BMS-512148-d4
Dapagliflozin-d4 (BMS-512148-d4) is deuterium labeled Dapagliflozin. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
Cat. No.: HY-10450S3
Synonyms: BMS-512148-13C6
Dapagliflozin- 13C6 (BMS-512148- 13C6) is 13C labeled Dapagliflozin. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
Cat. No.: HY-10450AR
CAS No.: 960404-48-2
Synonyms: BMS-512148 (2S)-1,2-propanediol, hydrate (Standard)
Research Areas:  

Metabolic Disease Cancer

Dapagliflozin ((2S)-1,2-propanediol, hydrate) (Standard) is the analytical standard of Dapagliflozin ((2S)-1,2-propanediol, hydrate). This product is intended for research and analytical applications. Dapagliflozin ((2S)-1,2-propanediol, hydrate) is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine . Dapagliflozin ((2S)-1,2-propanediol, hydrate) induces HIF1 expression and attenuates renal IR injury .
loading...
    loading...
Cat. No.: HY-I1198
CAS No.: 2169998-23-4
Synonyms: Oxo-Dapagliflozin
Target:  

Drug Metabolite

Research Areas:  

Inflammation/Immunology

Dapagliflozin keto impurity (Oxo-dapagliflozin) is an oxo metabolite and related impurity of Dapagliflozin (HY-10450). Dapagliflozin keto impurity can be characterized by 1H NMR, 13C NMR and HRMS, and can be used in studies related to Dapagliflozin impurities and metabolites .
loading...
    loading...
Cat. No.: HY-I1198R
CAS No.: 2169998-23-4
Synonyms: Oxo-Dapagliflozin (Standard)
Dapagliflozin keto impurity (Standard) (Oxo-dapagliflozin (Standard)) is the analytical standard of Dapagliflozin keto impurity (HY-I1198). This product is intended for research and analytical applications. Dapagliflozin keto impurity (Oxo-dapagliflozin) is an oxo metabolite and related impurity of Dapagliflozin (HY-10450). Dapagliflozin keto impurity can be characterized by 1H NMR, 13C NMR and HRMS, and can be used in studies related to Dapagliflozin impurities and metabolites .
loading...
    loading...
Cat. No.: HY-I1120R
CAS No.: 864070-37-1
Research Areas:  

Metabolic Disease

SGLT2-IN-1 (standard) is the analytical standard for SGLT2-IN-1. This product is used for research and analytical applications. SGLT2-IN-1 (Compound 5) is an inhibitor for sodium-dependent glucose cotransporter (SGLT2), with IC50 of 33 nM in CHO cells transfected with human SGLT2. SGLT2-IN-1 is selective for SGLT2 over SGLT1. SGLT2-IN-1 is an active metabolite of dapagliflozinactive metabolite of dapagliflozin.
loading...
    loading...
Cat. No.: HY-I1118
CAS No.: 872980-38-6
Target:  

Drug Intermediate

Research Areas:  

Others

Dapagliflozin impurity 112 is an impurity of Dapagliflozin (HY-10450).
loading...
    loading...